In a large population of people with diabetes, the use of GLP-1 receptor agonists was not linked to an increased risk for ...
NEW YORK, NY / ACCESSWIRE / January 15, 2025 / Laxxon Medical, a leading pharmaceutical technology company pioneering a new generation of advanced oral drug delivery systems, today announced the ...
A study found that disruptions in homeostasis from quick weight reduction by consuming GLP-1 drug can elevate cortisol - a ...
The race is on for new drugs that suppress appetite, improve glucose regulation and can replace injections. But do they ...
Weight loss jabs such as Wegovy are “lifelong treatments” and most people who stop taking them will lose the effects, a ...
Patients with overweight or obesity who used maridebart cafraglutide experienced significant weight loss at 1 year, according ...
Korea Joongang Daily on MSN3h
Hanmi seeks to gain on Wegovy with its own weight-loss drugHanmi Pharmaceutical Senior Vice President Choi In-young, head of the R&D center, speaks to Korean media outlets at a press ...
News Medical on MSN16h
Semaglutide improves glycemic control with automated insulin deliverySemaglutide combined with automated insulin delivery enhances glucose control in type 1 diabetes, lowering insulin ...
Civic Science on MSN9h
GLP-1 Trends by CivicScience: Current Users Report Shifts in Retail Shopping and Alcohol Consumption, Plus More InsightsThis is just a glimpse of the GLP-1 trends available to CivicScience clients. Want to see the full picture? Let’s talk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback